The Milne Institute for Healthcare Innovation
The Milne Institute for Healthcare Innovation is the result of a generous donation from George and Carol Milne. “As a scientist and a biomedical researcher with a broad interest in outcomes, it is clear that Gaylord fills a unique niche that is not well-represented in our country – patients recovering from devastating injuries or illnesses,” said George Milne, Jr., PhD, retired Executive Vice President of Global Research and Development and President of Central Research at Pfizer, Inc.
Housed on the Gaylord campus in Wallingford, Connecticut, the Milne Institute conducts research and develops evidence-based practices and applied technologies, which have the potential to change lives around the world, by leveraging Gaylord’s expertise in the care of brain and spinal cord injuries, complex strokes, amputations, and pulmonary diseases.
The Institute provides a collaborative, multidisciplinary environment for dedicated researchers to work with Gaylord's team of clinicians while partnering with corporations and foundations to conduct and disseminate data-driven research. All research and corporate partnerships are part of the Institute including two cross-pollinating centers: The Center for Research and Innovation and The Center for Applied Technologies.
“The national need for a resource that can effect profound outcomes for people of all ages is extraordinary. Not only will we have the ability to perform transformational research on cutting-edge technologies, but also research some of the more modest things that, in the end, can have an enormous impact on helping patients thrive.” George Milne, Jr., PhD
Milne Institute Leadership & Contact Information
The Milne Institute is led by Executive Director Peter Grevelding, PT, MSPT, NCS, and Medical Director, David Rosenblum, MD, a Gaylord physiatrist with nearly 30 years of research experience, including conducting research with the Spinal Cord Injury (SCI) Model System.
Peter Grevelding, Executive Director
David Rosenblum, MD, Medical Director
Paige Panda, Chief Development Officer, Senior Advisor to the President
Conducting Research at Gaylord
Through the Milne Institute for Healthcare Innovation Gaylord Specialty Healthcare offers patients the opportunity to participate in various research projects. Inpatients and outpatients who are eligible to enroll in appropriate studies are given the information necessary to make an informed decision regarding participation. Gaylord staff works with other collaborating facilities to conduct and participate in larger studies, including some at an international level. There are also Gaylord-specific studies that are designed and conducted by Gaylord staff. For questions, contact: [email protected] or [email protected]
All research projects conducted at Gaylord are reviewed by our Institutional Review Board, (IRB). This board includes professionals from disciplines throughout Gaylord, as well as community leaders. Upon IRB approval, the studies are conducted within the guidelines of the submitted protocol. Annual reviews and audits are conducted to ensure projects are compliant. All research projects have earned and maintain IRB approval.
Gaylord is IRB is compliant with U.S. Federal Government Department of Health and Human Service, Office for Human Research Protections. A Federal Wide Assurance, (FWA00010599) that is valid through Feb. 13, 2022, shows Gaylord’s commitment to comply with the requirements set forth in the regulations for the protection of human subjects. The Federal Wide Assurance defines the responsibilities of the Institution, the IRB, the IRB administrative office and staff, and the investigators to protect human research subjects. For questions, contact: [email protected] or [email protected].